Sanofi Pasteur

FLUZONE HIGH-DOSE QUADRIVALENT (2020/2021)

Manufacturer:

Sanofi Pasteur

Fluzone High-Dose Quadrivalent (2020/2021) HCPCS:

90662

HCPCS Code Descriptor:

Category:

CPT Drug Code

Fluzone High-Dose Quadrivalent (2020/2021) NDCs:

49281-0123-65

Primary Type:

Vaccine

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Intramuscular

Fluzone High-Dose Quadrivalent (2020/2021) CPT Codes:

Potential CPT administration codes for Fluzone High-Dose Quadrivalent (2020/2021) can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

49281-0123-65

About Fluzone High-Dose Quadrivalent (2020/2021):

FLUZONE HIGH-DOSE QUADRIVALENT (2020/2021) is a Vaccine drug manufactured by Sanofi Pasteur and administered via the Intramuscular route of administration. The CPT Drug Code: 90662 is aligned to the drug FLUZONE HIGH-DOSE QUADRIVALENT (2020/2021).

Fluzone High-Dose Quadrivalent, manufactured by Sanofi Pasteur Inc., is a high-dose seasonal flu vaccine used for immunization for the prevention of influenza caused by both influenza A subtype viruses and type B viruses. It is a four-component flu vaccine that contains four times the antigen as standard flu vaccines. This vaccine is only approved for those 65 and older.

ACCESS PRICING AND MORE BY REGISTERING

90662 Added Date:

NA

90662 Effective Date:

NA

90662 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fluzone High-Dose Quadrivalent (2020/2021) billing and coding information.
Our team did not identify a source for Fluzone High-Dose Quadrivalent (2020/2021) patient assistance information. Please reach out to our team if you feel that this is a mistake.
FLUZONE HIGH-DOSE QUADRIVALENT (2020/2021) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for FLUZONE HIGH-DOSE QUADRIVALENT (2020/2021). Please check back in a few weeks.